{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:55:40Z","timestamp":1790898940911,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Central Universities Postgraduate Innovation Project Fund","award":["lzujbky-2025-it35"],"award-info":[{"award-number":["lzujbky-2025-it35"]}]},{"name":"Central Incentive Fund for Regional S&T Development","award":["Grant No. 25ZYJA024"],"award-info":[{"award-number":["Grant No. 25ZYJA024"]}]},{"name":"Gansu Provincial Key Talent Program","award":["Grant No. 2025RCXM081"],"award-info":[{"award-number":["Grant No. 2025RCXM081"]}]},{"name":"Open Project of State Key Laboratory of Neurology and Oncology Drug Development","award":["Grant No. SKLSIM-F-2025107"],"award-info":[{"award-number":["Grant No. SKLSIM-F-2025107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16469-2","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:25:23Z","timestamp":1783304723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethyl caffeate reprograms tumor-associated macrophages to enhance CD8+ T-cell immunity in colorectal cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhixian","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"3","key":"16469_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"16469_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104775","volume":"212","author":"E Chen","year":"2025","unstructured":"Chen E, Zhou W. Immunotherapy in microsatellite-stable colorectal cancer: strategies to overcome resistance. Crit Rev Oncol Hematol. 2025;212:104775.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"16469_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"Bied M, Ho WW, Ginhoux F, Bl\u00e9riot C. Roles of macrophages in tumor development: a spatiotemporal perspective. Cell Mol Immunol. 2023;20(9):983\u201392.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"16469_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05777-4","volume":"150","author":"R Huang","year":"2024","unstructured":"Huang R, Kang T, Chen S. The role of tumor-associated macrophages in tumor immune evasion. J Cancer Res Clin Oncol. 2024;150(5):238.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"16469_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","volume":"131","author":"JH Rannikko","year":"2024","unstructured":"Rannikko JH, Hollm\u00e9n M. Clinical landscape of macrophage-reprogramming cancer immunotherapies. Br J Cancer. 2024;131(4):627\u201340.","journal-title":"Br J Cancer"},{"key":"16469_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22136995.","journal-title":"Int J Mol Sci"},{"key":"16469_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177:116930.","journal-title":"Biomed Pharmacother"},{"key":"16469_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jare.2024.12.043","volume":"76","author":"Y Liu","year":"2025","unstructured":"Liu Y, Tan H, Dai J, Lin J, Zhao K, Hu H, et al. Targeting macrophages in cancer immunotherapy: frontiers and challenges. J Adv Res. 2025;76:695\u2013713.","journal-title":"J Adv Res"},{"key":"16469_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156700","volume":"141","author":"Y Huang","year":"2025","unstructured":"Huang Y, Li G, Li D, Liu C, Chen M, Cai L, et al. Ethyl caffeate alleviates inflammatory response and promotes recovery in septic-acute lung injury via the TNF-\u03b1\/NF-\u03baB\/MMP9 axis. Phytomedicine. 2025;141:156700.","journal-title":"Phytomedicine"},{"key":"16469_CR10","doi-asserted-by":"crossref","unstructured":"10. Jiang L, Gu M, Xiao J, Zhao Y, Shen F, Guo X, Li H, Guo D, Li C, Zhu Q et al: Ethyl caffeate as a novel targeted inhibitor of 3CLpro with antiviral activity against porcine epidemic diarrhea virus. Virology. 2025;604:110406.","DOI":"10.1016\/j.virol.2025.110406"},{"issue":"1","key":"16469_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03690-5","volume":"25","author":"S Sang","year":"2025","unstructured":"Sang S, Han Y, Zhou H, Kang X, Gong Y. Network pharmacology and experimental analysis reveal Ethyl caffeate delays osimertinib resistance in lung cancer by suppression of MET. Cancer Cell Int. 2025;25(1):99.","journal-title":"Cancer Cell Int"},{"key":"16469_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myad114","author":"T Wang","year":"2023","unstructured":"Wang T, Pan M, Bao M, Bu Q, Yang R, Yang Y, et al. Ethyl caffeate combined with fluconazole exhibits efficacy against azole-resistant oropharyngeal candidiasis via the EFGR\/JNK\/c-JUN signaling pathway. Med Mycol. 2023. https:\/\/doi.org\/10.1093\/mmy\/myad114.","journal-title":"Med Mycol"},{"key":"16469_CR13","doi-asserted-by":"crossref","unstructured":"Xu S, Zuo A, Guo Z, Wan C: Ethyl Caffeate Ameliorates Collagen-Induced Arthritis by Suppressing Th1 Immune Response. J Immunol Res. 2017:7416792.","DOI":"10.1155\/2017\/7416792"},{"key":"16469_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107407","volume":"209","author":"JQ Hu","year":"2024","unstructured":"Hu JQ, Zheng DC, Huang L, Yang X, Ning CQ, Zhou J, et al. Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming. Pharmacol Res. 2024;209:107407.","journal-title":"Pharmacol Res"},{"issue":"3","key":"16469_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"21","key":"16469_CR16","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2021;184(21):5309\u201337.","journal-title":"Cell"},{"issue":"1","key":"16469_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01522-4","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun Q, Hong Z, Zhang C, Wang L, Han Z, Ma D. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. Signal Transduct Target Ther. 2023;8(1):320.","journal-title":"Signal Transduct Target Ther"},{"key":"16469_CR18","doi-asserted-by":"crossref","unstructured":"18. Ortiz-Mu\u00f1oz G, Brown M, Carbone CB, Pechuan-Jorge X, Rouilly V, Lindberg H, Ritter AT, Raghupathi G, Sun Q, Nicotra T et al: In situ tumour arrays reveal early environmental control of cancer immunity. Nature. 2023;618(7966):827\u2013833.","DOI":"10.1038\/s41586-023-06132-2"},{"key":"16469_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00784","volume":"11","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, Meylan M, de Reyni\u00e8s A, Saut\u00e8s-Fridman C, Fridman WH. The tumor microenvironment in the response to immune checkpoint blockade therapies. Front Immunol. 2020;11:784.","journal-title":"Front Immunol"},{"key":"16469_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440830","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yu M, Zhang S. The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies. Front Immunol. 2024;15:1440830.","journal-title":"Front Immunol"},{"key":"16469_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104452","volume":"88","author":"A Mezheyeuski","year":"2023","unstructured":"Mezheyeuski A, Backman M, Mattsson J, Mart\u00edn-Bernab\u00e9 A, Larsson C, Hrynchyk I, et al. An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. EBioMedicine. 2023;88:104452.","journal-title":"EBioMedicine"},{"issue":"5","key":"16469_CR22","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1093\/oncolo\/oyae013","volume":"29","author":"DC Guven","year":"2024","unstructured":"Guven DC, Kavgaci G, Erul E, Syed MP, Magge T, Saeed A, et al. The efficacy of immune checkpoint inhibitors in microsatellite stable colorectal cancer: a systematic review. Oncologist. 2024;29(5):e580\u2013600.","journal-title":"Oncologist"},{"issue":"17","key":"16469_CR23","doi-asserted-by":"publisher","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","volume":"115","author":"E Peranzoni","year":"2018","unstructured":"Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari-Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U S A. 2018;115(17):E4041-e4050.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"16469_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, Wu H, Jiang M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024;9(1):274.","journal-title":"Signal Transduct Target Ther"},{"key":"16469_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104204","volume":"200","author":"C Yang","year":"2024","unstructured":"Yang C, Zhao L, Lin Y, Wang S, Ye Y, Shen Z. Improving the efficiency of immune checkpoint inhibitors for metastatic pMMR\/MSS colorectal cancer: options and strategies. Crit Rev Oncol Hematol. 2024;200:104204.","journal-title":"Crit Rev Oncol Hematol"},{"key":"16469_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108962","volume":"237","author":"L Chen","year":"2022","unstructured":"Chen L, Jiang X, Li Y, Zhang Q, Li Q, Zhang X, et al. How to overcome tumor resistance to anti-PD-1\/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC. Clin Immunol. 2022;237:108962.","journal-title":"Clin Immunol"},{"key":"16469_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"16469_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli K, Pillarisetty VG, Kim TS. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 2022;29(1):10\u201321.","journal-title":"Cancer Gene Ther"},{"issue":"6","key":"16469_CR29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten K, Hu KH, Combes AJ, Samad B, Harwin T, Ray A, et al. Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer. Cancer Cell. 2022;40(6):624-638.e629.","journal-title":"Cancer Cell"},{"key":"16469_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1026954","volume":"13","author":"C Kerneur","year":"2022","unstructured":"Kerneur C, Cano CE, Olive D. Major pathways involved in macrophage polarization in cancer. Front Immunol. 2022;13:1026954.","journal-title":"Front Immunol"},{"issue":"1","key":"16469_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno.101001","volume":"15","author":"A Deng","year":"2025","unstructured":"Deng A, Fan R, Hai Y, Zhuang J, Zhang B, Lu X, et al. A STING agonist prodrug reprograms tumor-associated macrophage to boost colorectal cancer immunotherapy. Theranostics. 2025;15(1):277\u201399.","journal-title":"Theranostics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16469-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:39:09Z","timestamp":1790897949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16469"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16469-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental protocols were approved by the Animal Ethics Committee of the First Hospital of Lanzhou University (Approval No.: LDYYLL2026-672). The care and use of laboratory animals followed the Guidelines for the Welfare and Ethics of Laboratory Animals (Ministry of Science and Technology of the People\u2019s Republic of China). In addition, this study adhered to the ARRIVE guidelines (\n                      \n                      ) for reporting in vivo experiments to ensure transparency and reproducibility. All efforts were made to minimize animal use and suffering.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1170"}}